Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-24 @ 6:28 PM
NCT ID:
NCT03138668
Eligibility Criteria:
Inclusion Criteria:
* Participant who have given their written consent after understanding the content and limitations of the study.
* ASA 1-2
* BMI ≥ 18 or ≤ 30
Exclusion Criteria:
* Participants who can not cooperate in the study.
* Participants who can not speak or understand danish.
* Allergies to the drugs used in the study.
* Alcohol abuse, by the investigators judgement.
* Drug abuse, by the investigators judgement.
* Daily use of prescription required analgesic drugs within the last four weeks.
* Consumption of over the counter analgesic drugs within the last 48 hours.
* Neuromuscular defects, former surgery or trauma to the lower extremities. (Hip to knee)
* Broken skin or wounds on the lower extremities, that could be hindering in the evaluation of the anatomical distribution of the LFCN block.
* Diabetes Mellitus.
* Pregnant women (women in the fertile age must be using safe contraception and produce a negative urine-HCG test to be able to participate in the study).
* Large tattoos in the examination area.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03138668
Study Brief:
Protocol Section:
NCT03138668